» Articles » PMID: 34941770

Effect of Pulmonary Inflammation by Surface Functionalization of Zinc Oxide Nanoparticles

Overview
Journal Toxics
Date 2021 Dec 23
PMID 34941770
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Zinc oxide nanoparticles (ZnO NPs) are used in various industries such as food additives, cosmetics, and biomedical applications. In this study, we evaluated lung damage over time by three types of ZnO NPs (L-serine, citrate, and pristine) following the regulation of functional groups after a single intratracheal instillation to rats. The three types of ZnO NPs showed an acute inflammatory reaction with increased LDH and inflammatory cell infiltration in the alveoli 24 h after administration. Especially in treatment with L-serine, citrate ZnO NPs showed higher acute granulocytic inflammation and total protein induction than the pristine ZnO NPs at 24 h. The acute inflammatory reaction of the lungs recovered on day 30 with bronchoalveolar fibrosis. The concentrations of IL-4, 6, TNF-α, and eotaxin in the bronchoalveolar lavage fluid (BALF) decreased over time, and the levels of these inflammation indicators are consistent with the following inflammatory cell data and acute lung inflammation by ZnO NP. This study suggests that single inhalation exposure to functionalized ZnO NPs may cause acute lung injury with granulocytic inflammation. Although it can recover 30 days after exposure, acute pulmonary inflammation in surface functionalization means that additional studies of exposure limits are needed to protect the workers that produce it.

Citing Articles

Protective effect of zinc oxide nanoparticles synthesized using Cassia alata for DSS-induced ulcerative colitis in mice model.

Govindarasu M, Vaiyapuri M, Kim J Bioprocess Biosyst Eng. 2024; 47(8):1393-1407.

PMID: 38942827 DOI: 10.1007/s00449-024-03047-8.


Transcriptomic Profiling the Effects of Airway Exposure of Zinc Oxide and Silver Nanoparticles in Mouse Lungs.

Zhao L, Wang S, Ilves M, Lehtonen S, Saikko L, El-Nezami H Int J Mol Sci. 2023; 24(6).

PMID: 36982257 PMC: 10049322. DOI: 10.3390/ijms24065183.


Non-ROS-Mediated Cytotoxicity of ZnO and CuO in ML-1 and CA77 Thyroid Cancer Cell Lines.

Peters A, Weaver N, Monahan K, Kim K Int J Mol Sci. 2023; 24(4).

PMID: 36835463 PMC: 9964803. DOI: 10.3390/ijms24044055.

References
1.
Cho W, Choi M, Han B, Cho M, Oh J, Park K . Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol Lett. 2007; 175(1-3):24-33. DOI: 10.1016/j.toxlet.2007.09.008. View

2.
Cho W, Duffin R, Poland C, Howie S, MacNee W, Bradley M . Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect. 2010; 118(12):1699-706. PMC: 3002189. DOI: 10.1289/ehp.1002201. View

3.
Pasupuleti S, Alapati S, Ganapathy S, Anumolu G, Pully N, Prakhya B . Toxicity of zinc oxide nanoparticles through oral route. Toxicol Ind Health. 2011; 28(8):675-86. DOI: 10.1177/0748233711420473. View

4.
Huang C, Aronstam R, Chen D, Huang Y . Oxidative stress, calcium homeostasis, and altered gene expression in human lung epithelial cells exposed to ZnO nanoparticles. Toxicol In Vitro. 2009; 24(1):45-55. DOI: 10.1016/j.tiv.2009.09.007. View

5.
Lam H, Chen L, Ainsworth D, Peoples S, Amdur M . Pulmonary function of guinea pigs exposed to freshly generated ultrafine zinc oxide with and without spike concentrations. Am Ind Hyg Assoc J. 1988; 49(7):333-41. DOI: 10.1080/15298668891379855. View